Tyme Technologies, Inc. Stock
Equities
TYME
US90238J1034
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Barbara Galaini
AUD | Comptroller/Controller/Auditor | 66 | - |
John M. Rothman
PRN | Corporate Officer/Principal | 75 | 20-08-18 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |